Stocknear Logo Stocknear
/
Popular
Login

Adaptimmune Therapeutics

0.24
0.00 (0.00%)
At close: Apr 17, 2025, 3:59 PM
0.25
3.14%
After-hours: Apr 17, 2025, 07:56 PM EDT

Adaptimmune Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-70.81M -113.87M -165.46M -158.09M -130.09M -137.16M -95.51M -70.14M -71.58M
10.81M 9.45M 6.08M 6.57M 7.59M 8.01M 7.81M 5.42M 3.29M
12.05M 11.77M 18.24M 20.63M 10.41M 11.05M n/a 10.8M 8.82M
-29.62M -25.05M -1.53M 134.63M 56.05M 4.72M -45.34M 7.21M 12.5M
11.72M -23.19M 903K 1.17M -55K -185K 237K 341K -1.19M
n/a n/a n/a 5.82M 2.5M 1.06M 12.22M -7.95M n/a
-36.98M -25.05M -1.53M 134.63M 56.05M 4.72M -45.34M 7.21M 12.5M
-73.21M -140.88M -141.77M 10.73M -53.59M -112.51M -104.39M -54.31M -48.17M
n/a -4.88M -29.74M -8.78M -2.91M -3.07M -4.71M -25.01M -12.79M
n/a 45.26M 77.86M 207K 565K 1.48M 798K 369K 1.28M
n/a -75.95M -48.12M -139.76M -381.04M -27.28M -150.79M -171.33M -42.84M
44.06M 210.98M 166.99M 224.34M 105.02M 125.3M 138.04M 69.72M 73.38M
-103.01M 925K -77.86M -207K -565K -1.48M -798K 181K -1.28M
-58.95M 176.54M 89.14M 75.8M -278.92M 94.94M -17.46M -126.08M 17.75M
49.5M n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
77K 256K 50K 759K 5.66M 366K 3.04M 401K 17K
78.75M 880K 12.87M 3.29M 340.05M 366K 102.69M 103.57M 17K
-53.81M 37.41M -42.06M 90.18M 6.58M -17.57M -15.82M -74.5M -35.98M
-73.21M -145.76M -171.51M 1.95M -56.5M -115.58M -109.1M -79.33M -60.95M

Create Price Alert on ADAP

Your price alert will notify you when the stock price is above 0.24.

Add to Watchlist